Trifluridine/Tipiracil Combined With Oxaliplatin and Bevacizumab Versus XELOX Plus Bevacizumab in the First-line Treatment of Advanced Colorectal Cancer (TOBACO): a Randomized, Controlled, Phase II Study
Latest Information Update: 26 Oct 2021
At a glance
- Drugs Tipiracil/trifluridine (Primary) ; Bevacizumab; Capecitabine; Oxaliplatin
- Indications Adenocarcinoma; Colon cancer; Colorectal cancer
- Focus Therapeutic Use
- Acronyms TOBACO
- 19 Oct 2021 New trial record